Cargando…
PET and Optical Imaging of Caveolin-1 in Gastric Tumors
[Image: see text] Previous studies have suggested tumoral caveolin-1 (CAV1) as a predictive biomarker for the response to anti-HER2 antibody drug therapies in gastric tumors. In this study, radiolabeled and fluorescently labeled anti-CAV1 antibodies were developed and tested as an immunoPET or optic...
Autores principales: | Surendra Panikar, Sandeep, Shmuel, Shayla, Lewis, Jason S., Pereira, Patrícia M. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552508/ https://www.ncbi.nlm.nih.gov/pubmed/37810678 http://dx.doi.org/10.1021/acsomega.3c03614 |
Ejemplares similares
-
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
por: Pereira, Patrícia M. R., et al.
Publicado: (2022) -
In Vivo Biorthogonal Antibody Click for Dual Targeting and Augmented Efficacy in Cancer Treatment
por: Panikar, Sandeep Surendra, et al.
Publicado: (2023) -
Antibody-Targeted Imaging of Gastric Cancer
por: Mandleywala, Komal, et al.
Publicado: (2020) -
Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers
por: Rao, Yi, et al.
Publicado: (2023) -
Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
por: Sun, Der Sheng, et al.
Publicado: (2017)